Hanson McClain Advisors »

Rocket Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.6k 2.0k 3.26
2025-06-30 $1.6k 640 2.45
2025-03-31 $5.2k 698 7.43
2024-12-31 $241 23 10.52
2024-09-30 $204 11 18.55
2023-09-30 $123 6 20.50

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Rocket Pharmaceuticals

Rtw Investments
Maverick Capital
BlackRock
Vanguard Group
MPM Oncology Impact Management
Suvretta Capital Management
Millennium Management
Morgan Stanley
Monaco Asset Management SAM
Newtyn Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Geode Capital Management
Citadel Advisors
Two Sigma Advisers

View all funds holding Rocket Pharmaceuticals